Therapeutic use of the human papillomavirus vaccine on recurrent respiratory papillomatosis: a systematic review and meta-analysis

T Rosenberg, BB Philipsen, CS Mehlum… - The Journal of …, 2019 - academic.oup.com
Background Recurrent respiratory papillomatosis is a benign condition caused by human
papillomavirus (HPV). Surgery is the mainstay of treatment, but numerous adjuvant …

[HTML][HTML] Bevacizumab as treatment option for recurrent respiratory papillomatosis: a systematic review

L Pogoda, F Ziylan, DPJ Smeeing, FG Dikkers… - European Archives of …, 2022 - Springer
Purpose To this day, there is no cure for recurrent respiratory papillomatosis (RRP). Multiple
surgical procedures are performed to achieve symptom relief and prevention of airway …

Homozygous NLRP1 gain-of-function mutation in siblings with a syndromic form of recurrent respiratory papillomatosis

SB Drutman, F Haerynck, FL Zhong… - Proceedings of the …, 2019 - National Acad Sciences
Juvenile-onset recurrent respiratory papillomatosis (JRRP) is a rare and debilitating
childhood disease that presents with recurrent growth of papillomas in the upper airway …

[HTML][HTML] HPV E6 inhibits E6AP to regulate epithelial homeostasis by modulating keratinocyte differentiation commitment and YAP1 activation

W Yin, N Egawa, K Zheng, H Griffin, P Tian… - PLoS …, 2023 - journals.plos.org
Human papillomaviruses (HPV) cause persistent infections by modulating epithelial
homeostasis in cells of the infected basal layer. Using FUCCI and cell-cell competition …

[HTML][HTML] Human papillomavirus infection during pregnancy and childhood: a comprehensive review

A Ardekani, E Taherifard, A Mollalo, E Hemadi… - Microorganisms, 2022 - mdpi.com
Human papillomavirus (HPV), the most prevalent sexually transmitted disease worldwide, is
the causative agent for several genital and oropharyngeal cancers and a suspected agent …

The efficacy of human papillomavirus vaccination as an adjuvant therapy in recurrent respiratory papillomatosis

A Ponduri, MC Azmy, E Axler, J Lin… - The …, 2023 - Wiley Online Library
Objective To characterize the efficacy of human papillomavirus (HPV) vaccination as an
adjuvant therapy in recurrent respiratory papillomatosis (RRP). Data Sources PubMed …

Juvenile-onset recurrent respiratory papillomatosis in the United States, epidemiology and HPV types—2015–2020

R Amiling, E Meites, TD Querec, L Stone… - Journal of the …, 2021 - academic.oup.com
Background Juvenile-onset recurrent respiratory papillomatosis (JORRP) is a rare disease
characterized by the growth of papillomas in the respiratory tract. In the United States …

Interim results of a phase 1/2 open‐label study of INO‐3107 for HPV‐6 and/or HPV‐11‐associated recurrent respiratory papillomatosis

T Mau, MR Amin, PC Belafsky, SR Best… - The …, 2023 - Wiley Online Library
Objective To evaluate the safety, immunogenicity, and efficacy of INO‐3107, a DNA
immunotherapy designed to elicit targeted T‐cell responses against human papillomavirus …

Comparing KTP and CO2 laser excision for recurrent respiratory papillomatosis: A systematic review

J Yang, Z Xie, BC Seyler - Laryngoscope Investigative …, 2022 - Wiley Online Library
Objective The CO2 laser and 532 nm potassium titanyl phosphate (KTP) laser have been
applied to treat recurrent respiratory papillomatosis (RRP). This systematic review sought to …

A review of the risk factors associated with juvenile-onset recurrent respiratory papillomatosis: genetic, immune and clinical aspects

SL Li, W Wang, J Zhao, FZ Zhang, J Zhang… - World Journal of …, 2022 - Springer
Background Juvenile-onset recurrent respiratory papillomatosis (JoRRP) is one of the most
common benign lesions of hyperplastic respiratory epithelial tissue in children and is …